African Journal of Rheumatology

About this journal

The African Journal of Rheumatology (AJR) is a peer-reviewed, open-access journal dedicated to the dissemination of original research, clinical studies, and reviews related to rheumatic diseases in Africa. Its scope encompasses the full spectrum of rheumatic conditions, including rheumatoid arthritis, osteoarthritis, lupus, vasculitis, and other inflammatory and autoimmune disorders. The journal's editorial team ensures a diverse range of perspectives and contributions from renowned researchers, clinicians, and healthcare professionals across the continent.

AJR's key themes include the epidemiology, pathogenesis, diagnosis, treatment, and management of rheumatic diseases in African populations. It emphasizes research addressing the unique challenges and complexities of rheumatic diseases in the African context, such as limited access to healthcare, socioeconomic disparities, and the prevalence of specific disease subtypes. The journal also explores the impact of these diseases on patients' lives, their families, and communities.

The intended audience of AJR comprises rheumatologists, rheumatology trainees, general practitioners, and other healthcare professionals involved in the care of patients with rheumatic diseases. It serves as a valuable resource for clinicians seeking to stay updated on the latest advancements and best practices in the field. Additionally, the journal attracts researchers, public health professionals, and policymakers interested in understanding the burden of rheumatic diseases in Africa and developing strategies for prevention, control, and improved patient outcomes.

AJR plays a crucial role in advancing the understanding and management of rheumatic diseases in Africa by promoting research, education, and collaboration within the region. The journal's open-access nature ensures widespread accessibility to valuable scientific information, contributing to the development of innovative solutions for tackling the challenges associated with these debilitating conditions. Its high impact factor reflects the journal's significant contribution to the global rheumatic diseases literature and its influence on clinical practice and public health policy.